Sonoma Biotherapeutics
Claire Crowther, Ph.D., is Senior Project Manager at Sonoma Biotherapeutics. She has experience in program and alliance management for gene therapy drug development. She was most recently at Asklepios Biopharmaceutical (AskBio) where she managed gene therapy programs from early development through Phase 1 studies. Prior to AskBio, she worked as a postdoctoral fellow for Sandia National Laboratories as a part of the Joint BioEnergy Institute.
Claire earned her Ph.D. in chemistry from Arizona State University and B.S. in chemistry from Allegheny College.
This person is not in any offices
Sonoma Biotherapeutics
1 followers
Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.